Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level

Leukemia Research

Volumn 35, Issue 8, 2011, Pages 1114-1116

  Nagy, Zsófia ^a   Kajtár, Béla ^a   Jáksó, Pál ^a   Dávid, Mariann ^a   Kosztolányi, Szabolcs ^a   Hermesz, Judit ^a   Kereskai, László ^a   Pajor, László ^a   Alpár, Donát ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cytogenetic evolution; FISH; Motorized microscopy; Plasma cell disorder; Recurrent IGH translocation

Indexed keywords

PROTEIN P53;

ARTICLE; BONE MARROW BIOPSY; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 4; CLONE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE REARRANGEMENT; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; PLASMA CELL; PLASMA CELL DISORDER; PRIORITY JOURNAL;

BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 4; EVOLUTION, MOLECULAR; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PLASMA CELL; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC;

EID: 79960261804     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.02.010     Document Type: Article

References (8)

1. Fonseca R., Bergsagel P.L., Drach J., Shaughnessy J., Gutierrez N., Stewart A.K., et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 2009, 23:2210-2221.
2. Avet-Loiseau H., Facon T., Grosbois B., Magrangeas F., Rapp M.J., Harousseau J.L., et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 2002, 99:2185-2191.
3. Chng W.J., Glebov O., Bergsagel P.L., Kuehl W.M. Genetic events in the pathogenesis of multiple myeloma. Best Pract Res Clin Haematol 2007, 20:571-596.
4. Kaufmann H., Ackermann J., Baldia C., Nösslinger T., Wieser R., Seidl S., et al. IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma. Leukemia 2004, 18:1879-1882.
5. Chiecchio L., Dagrada G.P., Ibrahim A.H., Dachs Cabanas E., Protheroe R.K., Stockley D.M., et al. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context. Haematologica 2009, 94:1708-1713.
6. Avet-Loiseau H., Facon T., Daviet A., Godon C., Rapp M.J., Harousseau J.L., et al. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome. Cancer Res 1999, 59:4546-4550.
7. Fonseca R., Bailey R.J., Ahmann G.J., Rajkumar S.V., Hoyer J.D., Lust J.A., et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 2002, 100:1417-1424.
8. The European Myeloma Network Recommendations for FISH in multiple myeloma. General comments 2005, http://www.cytogenetics.org.uk/prof_standards/myeloma.htm.